期刊
JOURNAL OF DERMATOLOGICAL TREATMENT
卷 25, 期 5, 页码 375-379出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/09546634.2012.757285
关键词
actinic keratosis; topical treatment; efficiency; pain; patient perspectives; interview
类别
资金
- LEO Pharma
- Astellas
- Basilea Pharma
- Pfizer
Objectives: In recent years, a number of topical treatments suitable for field-directed therapy of actinic keratosis (AK) have been developed. Non-surgical treatment of AK however requires strict adherence by patients. Patients' views on the different possible topical treatments are therefore relevant to the choice of treatment. The aim of the study was to disclose the silent perspectives by focusing on user experiences and individual perspectives on topical treatment. Materials and methods: Telephone interviews and face-to-face interviews were conducted with patients having had treatment with one or more of the following: imiquimod 5%, diclofenac sodium gel 3%, 5-fluorouracil (5-FU) cream 5% or photodynamic therapy. Results: 24 patients with AK were interviewed. Experiences of pain, discharging ulcers and efficiency of the treatment were of major importance. There was a general focus on appearance, social contacts and leisure time, although this appeared to be of lesser importance. Patients' perception of treatment instructions identified a risk of misunderstandings. Conclusion: Patients are primarily concerned with therapeutic efficiency. Pain and ulcers are central indicators, but appearance, social contacts and leisure time can also be considered as additional indicators of satisfaction. A firm focus on patient instruction is suggested.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据